Qiagen NV | QIA - Loan Capital


Qiagen NV reported $1.65B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
argenx SE USD 35.57M 3.05M Jun/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Moderna USD 603M 7M Mar/2026
Organon & Co USD 8.55B 75M Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
Revvity USD 2.63B 836K Mar/2026
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026